Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Mesalazine for Oral Ulcers in Crohn's Disease
NCT02769494Phase 3Withdrawn
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in Oral ulcer, sponsored by Xijing Hospital of Digestive Diseases. Planned start Mar 2016; status: withdrawn.
02
Drugs
Salcrozine
03
Conditions
Oral ulcer
Beyond the preview
Go deeper on NCT02769494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769494.